Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Cited by (1,001)

Items 401–500 of 1,001

1. Primary Antiretroviral Drug Resistance among HIV Type 1-Infected Individuals in Brazil
   Eduardo Sprinz, Eduardo Martins Netto, Maria Patelli Juliani Souza Lima, Juvênao J.D. Furtado, Margareth da Eira, Roberto Zajdenverg, José Valdez Madruga, David Salomão Lewi, Alcyone Artioli Machado, R. J. Pedro et al. · 2009 · AIDS Research and Human Retroviruses
2. Clinical pharmacodynamics of HIV-1 protease inhibitors: use of inhibitory quotients to optimise pharmacotherapy
   Gene D. Morse, Linda M. Catanzaro, Edward P. Acosta · 2006 · The Lancet Infectious Diseases
3. CD133+ Hematopoietic Progenitor Cells Harbor HIV Genomes in a Subset of Optimally Treated People With Long-Term Viral Suppression
   Lucy A. McNamara, Adewunmi Onafuwa-Nuga, Nadia T. Sebastian, James Riddell, Dale Lee Bixby, Kathleen L. Collins · 2013 · The Journal of Infectious Diseases
4. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy
   Jun Chen, Jingna Xun, Junyang Yang, Yongjia Ji, Li Liu, Tangkai Qi, Zhenyan Wang, Renfang Zhang, Yinzhong Shen, Rosalie Ponte et al. · 2018 · Clinical Infectious Diseases
5. Phylogenetic approach to recover integration dates of latent HIV sequences within-host
   Bradley R. Jones, Natalie N. Kinloch, J. Horacsek, Bruce Ganase, Marianne Harris, P. Richard Harrigan, Richard Brad Jones, Mark A. Brockman, Jeffrey B. Joy, Art F. Y. Poon et al. · 2018 · Proceedings of the National Academy of Sciences
6. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals
   F. Harrison Omondi, Sandali Chandrarathna, Shariq Mujib, Chanson J. Brumme, Steven W. Jin, Hanwei Sudderuddin, Rachel L. Miller, Asa Rahimi, Oliver B Laeyendecker, Phil Bonner et al. · 2019 · Journal of Virology
7. Increased Expression of TLR3 in Lymph Nodes during Simian Immunodeficiency Virus Infection: Implications for Inflammation and Immunodeficiency
   Sonali Sanghavi, Todd A. Reinhart · 2005 · The Journal of Immunology
8. Low-level HIV-1 replication and the dynamics of the resting CD4+T cell reservoir for HIV-1 in the setting of HAART
   Ahmad R. Sedaghat, Robert F. Siliciano, Claus O. Wilke · 2008 · BMC Infectious Diseases
9. Cell–cell contact viral transfer contributes to HIV infection and persistence in astrocytes
   Xiaoyu Luo, Johnny J. He · 2014 · Journal of NeuroVirology
10. Epigenetic modulation of host: new insights into immune evasion by viruses
    Dwaipayan Adhya, Anirban Basu · 2010 · Journal of Biosciences
11. Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection
    Guido Ferrari, Barton F. Haynes, Scott Koenig, Jeffrey L. Nordstrom, David M. Margolis, Georgia D. Tomaras · 2016 · Nature Reviews Drug Discovery
12. Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy
    Eunok Lee, Peter Bacchetti, Jeffery Milush, Wei Shao, Eli Boritz, Daniel C. Douek, Rémi Fromentin, Teri J. Liegler, Rebecca Hoh, Steven G. Deeks et al. · 2019 · Frontiers in Microbiology
13. Effect of Highly Active Antiretroviral Therapy on Viral Burden in the Lungs of HIV‐Infected Subjects
    Homer L. Twigg, Michael D. Weiden, Fred T. Valentine, Carol T Schnizlein-Bick, Roland L. Bassett, Lu Zheng, Lawrence Joseph Wheat, Richard B. Day, Helen Rominger, Ronald G. Collman et al. · 2007 · The Journal of Infectious Diseases
14. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
    Fabrizio Ensoli, Aurelio Cafaro, Anna Casabianca, Antonella Tripiciano, Stefania Bellino, Olimpia Longo, Vittorio Francavilla, Orietta Picconi, Cecilia Sgadari, Sonia Moretti et al. · 2015 · Retrovirology
15. Immune Control of HIV
    Muthukumar Balasubramaniam, Jui Pandhare, Chandravanu Dash · 2019 · JoLS Journal of Life Sciences
16. HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program
    Anne Derache, Hyoung‐Shik Shin, Maya Balamane, Elizabeth White, Dennis M Israelski, Jeffrey David Klausner, A.H. Freeman, David Allan Katzenstein · 2015 · PLoS ONE
17. Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells
    Gautam Kumar Sahu, Kaori Sango, Nithianandan Selliah, Qiangzhong Ma, Gail Skowron, Richard Paul Junghans · 2013 · Virology
18. Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells
    Ruian Ke, Sharon R. Lewin, Julian H. Elliott, Alan S. Perelson · 2015 · PLoS Pathogens
19. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.
    Guylaine Haché, Louis M. Mansky, Reuben S. Harris · 2006 · PubMed
20. Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1
    Mireille Centlivre, Nicolas Legrand, Sofieke Klamer, Ying Poi Liu, Karin Jasmijn von Eije, Martino Böhne, Esther Siteur-van Rijnstra, Kees C. Weijer, Bianca Blom, Carlijn Voermans et al. · 2013 · Molecular Therapy — Nucleic Acids
21. HIV RNA Suppression and Immune Restoration: Can We Do Better?
    Marilia Rita Pinzone, Michelino Di Rosa, Bruno Santi Cacopardo, Giuseppe Nunnari · 2012 · Clinical and Developmental Immunology
22. CCR5 Gene Editing of Resting CD4+ T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice
    Guohua Yi, Jang Gi Choi, Preeti Bharaj, Sojan Abraham, Ying Dang, Tal Kafri, Ogechika K. Alozie, Manjunath N Manjunath, Premlata Shankar · 2014 · Molecular Therapy — Nucleic Acids
23. Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS
    Vincent C. Marconi, Greg Grandits, Jason F. Okulicz, Glenn W. Wortmann, Anuradha Ganesan, Nancy F. Crum‐Cianflone, Michael Alan Polis, Michael L. Landrum, Matthew J. Dolan, Sunil K. Ahuja et al. · 2011 · PLoS ONE
24. Predictors of Residual Viremia in HIV‐Infected Patients Successfully Treated with Efavirenz and Lamivudine plus either Tenofovir or Stavudine
    Diane V. Havlir, Kersten K. Koelsch, Matthew C. Strain, Nicolas Margot, Biao Lu, Caroline C. Ignacio, Michael D. Miller, Joseph K. Wong, Gilead 903 Study Team · 2005 · The Journal of Infectious Diseases
25. Early Therapy in HIV-1-Infected Children: Effect on HIV-1 Dynamics and HIV-1-Specific Immune Response
    Marisa Zanchetta, A. Anselmi, Daniela Vendrame, Osvalda Rampon, Carlo Giaquinto, Antonio Mazza, Daniele Accapezzato, Vincenzo Barnaba, Anita De Rossi · 2008 · Antiviral Therapy
26. Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency
    Zichong Li, Jun Wu, Leonard Chávez, Rebecca Hoh, Steven G. Deeks, Satish K. Pillai, Qiang Zhou · 2019 · PLoS Pathogens
27. Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women
    Mark D Pankau, Daniel B. Reeves, Elias Harkins, Keshet Ronen, Walter Godfrey Jaoko, Kishor N. Mandaliya, Susan Marie Graham, R. Scott McClelland, Frederick A. Matsen IV, Joshua Tisdell Schiffer et al. · 2020 · PLoS Pathogens
28. Immunization of Macaques with Single-Cycle Simian Immunodeficiency Virus (SIV) Stimulates Diverse Virus-Specific Immune Responses and Reduces Viral Loads after Challenge with SIVmac239
    David T. Evans, Jennifer E. Bricker, Hannah B. Sanford, Sabine M. Lang, Angela Carville, Barbra A. Richardson, Michael Piatak, Jeffrey D. Lifson, Keith G. Mansfield, Ronald C. Desrosiers · 2005 · Journal of Virology
29. The cell biology of HIV-1 latency and rebound
    Uri R. Mbonye, Jonathan Karn · 2024 · Retrovirology
30. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation
    Miguel Stevens, Jan M. Balzarini, Oriana Tabarrini, Graciela Andreï, Robert Snoeck, Violetta Cecchetti, Arnaldo Fravolini, Erik De Clercq, Christophe C. Pannecouque · 2005 · Journal of Antimicrobial Chemotherapy
31. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy
    Timothy J. Henrich, Kristen S. Hobbs, Emily Hanhauser, Eileen P. Scully, Louise E. Hogan, Yvonne Robles, Kaitlyn S. Leadabrand, Francisco M. Marty, Christine D. Palmer, Stéphanie Jost et al. · 2017 · The Journal of Infectious Diseases
32. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
    Wesley de Jong, Joeri L. Aerts, Sabine Danielle Allard, Christian Brander, Jozefien Buyze, Éric Florence, Eric C. M. Van Gorp, Guido L. Vanham, Lorna Leal, Beatriz Mothe et al. · 2019 · Trials
33. HIV-1 variants are archived throughout infection and persist in the reservoir
    Kelsie Brooks, Bradley R. Jones, Dario Alberto Dilernia, Daniel J. Wilkins, Daniel T. Claiborne, Samantha McInally, Jill W Gilmour, William Kilembe, Jeffrey B. Joy, Susan A Allen et al. · 2020 · PLoS Pathogens
34. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques
    Julia Bergild McBrien, Andrew Kam Ho Wong, Erick White, Diane G. Carnathan, John H. Lee, Jeffrey T. Safrit, Thomas H. Vanderford, Mirko Paiardini, Ann Chahroudi, Guido Silvestri · 2020 · Journal of Virology
35. Human Immunodeficiency Virus Reactivation by Phorbol Esters or T-Cell Receptor Ligation Requires both PKCα and PKCθ
    Sergey A. Trushin, Gary D. Bren, Susana Asin, Kevin N. Pennington, Carlos V. Payá, Andrew D. Badley · 2005 · Journal of Virology
36. Long HIV Type 1 Reverse Transcripts Can Accumulate Stably within Resting CD4 + T Cells While Short Ones Are Degraded
    William J. Swiggard, Una O’Doherty, David McGain, Deepa Jeyakumar, Michael H. Malim · 2004 · AIDS Research and Human Retroviruses
37. Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation
    Hung‐Chih Yang, Lin Shen, Robert F. Siliciano, Joel L. Pomerantz · 2009 · Proceedings of the National Academy of Sciences
38. Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy
    María Salgado, Seyed Alireza Rabi, Karen A. O’Connell, Robert W. Buckheit, Justin R. Bailey, Amina A. Chaudhry, Autumn R. Breaud, Mark A. Marzinke, William A. Clarke, Joseph B. Margolick et al. · 2011 · Retrovirology
39. Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy
    Sharon A. Riddler, Evgenia Aga, Ronald J. Bosch, Barbara Bastow, Margaret Anne Bedison, David Vagratian, Florin Vaida, Joseph J. Eron, Rajesh Tim Gandhi, John W. Mellors · 2015 · The Journal of Infectious Diseases
40. The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
    María Rosa López‐Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutiérrez, Sara Rodríguez-Mora, Mayte Coiras, José Alcamı́, Santiago Moreno · 2017 · Scientific Reports
41. Next-generation in situ hybridization approaches to define and quantify HIV and SIV reservoirs in tissue microenvironments
    Claire Deléage, Chi Ngai Chan, Kathleen Busman‐Sahay, Jacob D. Estes · 2018 · Retrovirology
42. Accumulation of Cytotoxic CD16 + NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy
    Jamie L. Schafer, Haiying Li, Tristan I. Evans, Jacob D. Estes, Roger Keith Reeves · 2015 · Journal of Virology
43. Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific
    Kazuo Suzuki, Takaomi Ishida, Makoto Yamagishi, Chantelle Ahlenstiel, Sanjay Swaminathan, Katharine Marks, Daniel D. Murray, Erin M. McCartney, Michael R. Beard, Marina R. Alexander et al. · 2011 · RNA Biology
44. Nanotechnology approaches to eradicating HIV reservoirs
    Shijie Cao, Kim A. Woodrow · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
45. The role of CD32 during HIV-1 infection
    Lynn N. Bertagnolli, Jennifer A. White, Francesco Roberto Simonetti, Subul A. Beg, Jun Lai, Costin Tomescu, Alexandra J. Murray, Annukka A.R. Antar, Hao Zhang, Joseph B. Margolick et al. · 2018 · Nature
46. First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
    Denis Beckford-Vera, Robert R. Flavell, Youngho Seo, Enrique Martinez-Ortiz, Maya Aslam, Cassandra Thanh, Emily A. Fehrman, Marion Pardons, Shreya Kumar, Amelia N. Deitchman et al. · 2022 · Nature Communications
47. Human Immunodeficiency Virus Infection : from Biological Observations to Mechanistic Mathematical Modelling
    Gennady Alekseevich Bocharov, В. А. Черешнев, I. Gainova, Sergei I. Bazhan, B.A. Bachmetyev, Jordi M. Argilaguet, Javier P. Martínez, Andreas Meyerhans · 2012 · Mathematical Modelling of Natural Phenomena
48. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research
    Melissa J. Churchill, Daniel Cowley, Steve L Wesselingh, Paul R. Gorry, Lachlan R. Gray · 2014 · Journal of NeuroVirology
49. HIV-1 functional cure: will the dream come true?
    Chao Liu, Xiancai Ma, Bingfeng Liu, Cancan Chen, Hui Zhang · 2015 · BMC Medicine
50. Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus
    George J. Leslie, Jianbin Wang, Max W. Richardson, Beth Haggarty, Kevin L. Hua, Jennifer Duong, Anthony J. Secreto, Andrea P. O. Jordon, Josephine Romano, Kritika Elitza Kumar et al. · 2016 · PLoS Pathogens
51. Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy
    Surya Kumari Vadrevu, Irena Trbojević‐Akmačić, Andrew V. Kossenkov, Florent Colomb, Leila B. Giron, Alitzel Anzurez, Kenneth Lynn, Karam Mounzer, ALAN L. LANDAY, Robert C. Kaplan et al. · 2018 · Journal of Leukocyte Biology
52. Improved assays to measure and characterize the inducible HIV reservoir
    Marta Massanella, Christina Yek, Steven M. Lada, Masato Nakazawa, Neda Shefa, Karissa Huang, Douglas D. Richman · 2018 · EBioMedicine
53. HIV-1 Proviral Transcription and Latency in the New Era
    Ashutosh Shukla, Nora-Guadalupe P. Ramirez, Iván D’Orso · 2020 · Viruses
54. HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo
    Colby R. Maldini, Kevin Gayout, Rachel S. Leibman, Derrick L. Dopkin, Joshua P. Mills, Xiaochuan Shan, Joshua A. Glover, James L. Riley · 2020 · Molecular Therapy
55. Past HIV-1 Medications and the Current Status of Combined Antiretroviral Therapy Options for HIV-1 Patients
    Matthew R. Weichseldorfer, Marvin S. Reitz, Olga Latinovic · 2021 · Pharmaceutics
56. Predictors of Virological Outcome and Safety in Primary HIV Type 1-Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005
    Bruno Hoen, David A. Cooper, Fiona C. Lampe, L. Perrin, Nathan Clumeck, Andrew N. Phillips, Li-Zhee Goh, Stefan Lindbäck, D. Séréni, Brian Gazzard et al. · 2007 · Clinical Infectious Diseases
57. Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection
    Mireia Arnedo‐Valero, Felipe García, C. Gil, T. Guila, Eloísa Felipe Fumero, Pedro Castro, J. L. Blanco, Josep Maria Miró, Tomàs Pumarola, José M. Gatell · 2005 · Clinical Infectious Diseases
58. Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
    Justin L. Harper, Susan Pereira Ribeiro, Chi Ngai Chan, Malika Aïd, Claire Deléage, Luca Micci, María Pino, Barbara Cervasi, Gopalan Raghunathan, Eric Rimmer et al. · 2022 · Journal of Clinical Investigation
59. Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells
    Carolyn Chu, Daniele Armenia, Charles Walworth, Maria Mercedes Santoro, Robert W. Shafer · 2022 · Clinical Microbiology Reviews
60. During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ
    Alessandra Ruggiero, Ward De Spiegelaere, Alessandro Cozzi‐Lepri, Maja Kiselinova, Georgios P. Pollakis, Apostolos I. Beloukas, Linos Vandekerckhove, Matthew C. Strain, Douglas D. Richman, Andrew N. Phillips et al. · 2015 · EBioMedicine
61. Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors
    Stuart R. Jefferys, Samuel D. Burgos, Jackson J. Peterson, Sara R. Selitsky, Anne‐Marie W. Turner, Lindsey Ingerman James, Yi‐Hsuan Tsai, Alisha R. Coffey, David M. Margolis, Joel S. Parker et al. · 2021 · PLoS Pathogens
62. Targeted Immune Interventions for an HIV-1 Cure
    Matthieu Perreau, Riddhima Banga, Giuseppe Pantaleo · 2017 · Trends in Molecular Medicine
63. Finding a cure for HIV: will it ever be achievable?
    Sharon R. Lewin, Vanessa A. Evans, Julian H. Elliott, Bruno Spire, Nicolas Chomont · 2011 · Journal of the International AIDS Society
64. On-chip Extraction of Intracellular Molecules in White Blood Cells from Whole Blood
    Jongchan Choi, Ji-chul Hyun, Sung Hoon Yang · 2015 · Scientific Reports
65. Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation
    Trevor A. Crowell, James L. K. Fletcher, Irini Sereti, Suteeraporn Pinyakorn, Robin L. Dewar, Shelly J. Krebs, Nitiya Chomchey, Rungsun Rerknimitr, Alexandra Schuetz, Nelson L. Michael et al. · 2016 · Journal of the International AIDS Society
66. Post-translational Modification-Based Regulation of HIV Replication
    Lin Chen, Oliver Till Keppler, Christian Wilfried Scholz · 2018 · Frontiers in Microbiology
67. Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech
    Subbroto Kumar Saha, Forhad Karim Saikot, Md. Shahedur Rahman, Mohammad Abu Hena Mostofa Jamal, S.M. Khaledur Rahman, S. M. Riazul Islam, Ki‐Hyun Kim · 2018 · Molecular Therapy — Nucleic Acids
68. Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
    Jana L. Jacobs, Elias Konstantine Halvas, Melissa A. Tosiano, John W. Mellors · 2019 · Frontiers in Microbiology
69. Epigenetic Mechanisms of HIV-1 Persistence
    Roxane Verdikt, Olivier Hernalsteens, Carine M. Van Lint · 2021 · Vaccines
70. Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART
    Charline Bacchus, Mark D. Fitch, Jori Symons, Mohamed Abdel‐Mohsen, Daniel B. Reeves, Rebecca Hoh, Mars Stone, Joseph B Hiatt, Peggy Kim, Abha Chopra et al. · 2021 · PLoS Pathogens
71. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies
    Edward F. Kreider, Katharine J. Bar · 2022 · Current HIV/AIDS Reports
72. Defective HIV-1 genomes and their potential impact on HIV pathogenesis
    Jeffrey Kuniholm, Carolyn Coote, Andrew J. Henderson · 2022 · Retrovirology
73. Regulatory B Cells Inhibit Cytotoxic T Lymphocyte (CTL) Activity and Elimination of Infected CD4 T Cells after In Vitro Reactivation of HIV Latent Reservoirs
    Basile T. Siewe, Jennillee Wallace, Sonya Rygielski, Jack T. Stapleton, Jeffrey N. Martin, Steven G. Deeks, ALAN L. LANDAY · 2014 · PLoS ONE
74. Creating genetic resistance to HIV
    John Burnett, John A. Zaia, John J. Rossi · 2012 · Current Opinion in Immunology
75. Anti-proliferative therapy for HIV cure: a compound interest approach
    Daniel B. Reeves, Elizabeth R. Duke, Sean M. Hughes, Martin Prlic, Florian Hladik, Joshua Tisdell Schiffer · 2017 · Scientific Reports
76. Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency
    Zhuo Wang, Hong Shang, Yongjun Jiang · 2017 · Frontiers in Immunology
77. Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda
    Jessica L. Prodger, Adam A. Capoferri, Katherine M. Yu, Jun Lai, Steven James Reynolds, Jingo Kasule, Taddeo Kityamuweesi, Paul Buule, David Serwadda, Kyungyoon J. Kwon et al. · 2020 · JCI Insight
78. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2020 · The Journal of Infectious Diseases
79. Exosomes in HIV infection
    Jing Chen, Chuanyun Li, Rong Li, Huan Chen, Dexi Chen, Weihua Li · 2021 · Current Opinion in HIV and AIDS
80. Host Genetic Influences on Highly Active Antiretroviral Therapy Efficacy and AIDS-Free Survival
    Sher L. Hendrickson, Lisa P. Jacobson, George W. Nelson, John Phair, James A. Lautenberger, Randall C. Johnson, Lawrence Kingsley, Joseph B. Margolick, Roger Detels, James J. Goedert et al. · 2008 · JAIDS Journal of Acquired Immune Deficiency Syndromes
81. The therapeutic potential of epigenetic manipulation during infectious diseases
    Joby Cole, Paul Morris, Mark J. Dickman, David Harold Dockrell · 2016 · Pharmacology & Therapeutics
82. Host factors regulating post-integration latency of HIV
    Samuel A. Williams, Warner C. Greene · 2005 · Trends in Microbiology
83. HIV Medicine 2005
    Christian Hoffmann, Rockstroh Jk, Bernd S. Kamps · 2005
84. MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases
    Xiaolei Huang, Li Zhang, Jianping Li, Yujie Wang, Yu Duan, Jing Wang · 2015 · Autoimmunity
85. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
    Genevieve Elizabeth Martin, Matthew J. Pace, John Patrick Thornhill, Chansavath Phetsouphanh, Jodi Meyerowitz, Morgane Gossez, Emily Hopkins, Helen Brown, Nicola Robinson, Natalia J. Olejniczak et al. · 2018 · Frontiers in Immunology
86. Measuring the Success of HIV-1 Cure Strategies
    Jordan Thomas, Alessandra Ruggiero, William A. Paxton, Georgios P. Pollakis · 2020 · Frontiers in Cellular and Infection Microbiology
87. Advances in HIV diagnosis and monitoring
    Md Alamgir Kabir, Hussein Zilouchian, Massimo Caputi, Waseem Asghar · 2020 · Critical Reviews in Biotechnology
88. Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
    Jennifer M. Zerbato, Georges Khoury, Wei Dong Zhao, Matthew J. Gartner, Rachel D. Pascoe, Ajantha Rhodes, Ashanti Dantanarayana, Megan Gooey, Jenny L. Anderson, Peter Bacchetti et al. · 2021 · EBioMedicine
89. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques
    Carolina Garrido, Alan Dale Curtis, Maria L. Dennis, Sachi Pathak, Hongmei Gao, David C. Montefiori, Mark A. Tomai, Christopher B. Fox, Pamela A. Kozlowski, Trevor Scobey et al. · 2021 · Science Immunology
90. Delayed antiretroviral therapy in HIV-infected individuals leads to irreversible depletion of skin- and mucosa-resident memory T cells
    Simona Saluzzo, Ram Vinay Pandey, Laura Marie Gail, Ruth Dingelmaier‐Hovorka, Lisa Kleißl, Lisa Ellen Shaw, Bärbel Reininger, Denise Atzmüller, Johanna Strobl, Veronique Touzeau‐Römer et al. · 2021 · Immunity
91. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection
    Matsuda, Kouki, Maeda, Kenji · 2024 · International Journal of Molecular Sciences
92. Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
    Caroline Dufour, Corentin Richard, Marion Pardons, Marta Massanella, Antoine Ackaoui, Ben Murrell, Bertrand Routy, Réjean Thomas, Jean‐Pierre Routy, Rémi Fromentin et al. · 2023 · Nature Communications
93. CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness
    Simona Mutascio, Talia M. Mota, Lavinia Franchitti, Ashish Sharma, Abigail Willemse, Sydney N. Bergstresser, Hong Wang, Maura Statzu, Gregory K. Tharp, Jared Weiler et al. · 2023 · Immunity
94. Recent trends in HIV-1 drug resistance
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2013 · Current Opinion in Virology
95. Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection
    Hartmut Martin Hanauske-Abel, Deepti Saxena, Paul E Palumbo, Axel-Rainer Hanauske, Augusto Ducati Luchessi, Tavane David Cambiaghi, Mainul Hoque, Michael Spino, Darlene D’Alliessi Gandolfi, Debra S. Heller et al. · 2013 · PLoS ONE
96. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
    Mateusz Stoszko, Elisa De Crignis, Casper Rokx, Mir Mubashir Khalid, Cynthia Lungu, Robert-Jan T. S. Palstra, Tsung Wai Kan, Charles A. Boucher, Annelies Verbon, Emily C. Dykhuizen et al. · 2015 · EBioMedicine
97. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination
    David R. Martinez, Sallie R. Permar, Genevieve G. Fouda · 2015 · Clinical and Vaccine Immunology
98. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection
    Priyanka Uprety, Kunjal Patel, Brad Karalius, Carrie Ziemniak, Ya Hui Chen, Sean S. Brummel, Suzanne M. Siminski, Russell B. Van Dyke, George R. Seage, Deborah Persaud et al. · 2017 · Clinical Infectious Diseases
99. Advancements in Developing Strategies for Sterilizing and Functional HIV Cures
    Wei Xu, Haoyang Li, Qian Wang, Chen Hua, Hanzhen Zhang, Weihua Li, Shibo Jiang, Lu Lu · 2017 · BioMed Research International
100. Effects of exosome on the activation of CD4+ T cells in rhesus macaques: a potential application for HIV latency reactivation
     Xiaowu Hong, Blake Schouest, Huanbin Xu · 2017 · Scientific Reports